Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism WFDC2 modulators(WAP four-disulfide core domain 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrial Carcinoma | Preclinical | US | 25 May 2023 |